Similar articles for PMID: 8004831

Year	Number of Results
1980	1
1981	1
1986	1
1987	2
1988	1
1989	1
1990	2
1993	4
1994	5
1995	2
1996	2
1997	3
1998	2
1999	2
2000	2
2001	3
2002	2
2003	1
2004	6
2005	3
2006	6
2007	4
2008	6
2009	3
2010	2
2014	1
2015	1
2016	2
2021	1
2022	1
2024	0

1

Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group.

Donadio JV, Bergstralh EJ, Offord KP, Holley KE, Spencer DC. Donadio JV, et al. Clin Nephrol. 1994 Feb;41(2):65-71. Clin Nephrol. 1994. PMID: 8004831 Clinical Trial.

2

Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.

Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC; HKVIN Study Group. Li PK, et al. Am J Kidney Dis. 2006 May;47(5):751-60. doi: 10.1053/j.ajkd.2006.01.017. Am J Kidney Dis. 2006. PMID: 16632013 Clinical Trial.

3

A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.

Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. Manno C, et al. Am J Kidney Dis. 2007 Jun;49(6):763-75. doi: 10.1053/j.ajkd.2007.03.013. Am J Kidney Dis. 2007. PMID: 17533019

4

Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.

Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S. Parinyasiri U, et al. J Med Assoc Thai. 2004 Feb;87(2):143-9. J Med Assoc Thai. 2004. PMID: 15061297

5

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group. Esnault VL, et al. Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006. Clin Ther. 2008. PMID: 18405787 Clinical Trial.

6

Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.

Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G. Bazzi C, et al. J Nephrol. 2009 May-Jun;22(3):387-96. J Nephrol. 2009. PMID: 19557716

7

Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study.

Limardo M, Imbasciati E, Ravani P, Surian M, Torres D, Gregorini G, Magistroni R, Casellato D, Gammaro L, Pozzi C; Rene e Gravidanza Collaborative Group of the Italian Society of Nephrology. Limardo M, et al. Am J Kidney Dis. 2010 Sep;56(3):506-12. doi: 10.1053/j.ajkd.2010.03.033. Am J Kidney Dis. 2010. PMID: 20599307

8

NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).

National Toxicology Program. National Toxicology Program. Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340. Natl Toxicol Program Tech Rep Ser. 1993. PMID: 12616289 Free article.

9

The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.

Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. Moriyama T, et al. Clin Exp Nephrol. 2004 Sep;8(3):237-42. doi: 10.1007/s10157-004-0298-7. Clin Exp Nephrol. 2004. PMID: 15480901 Clinical Trial.

10

Factors predicting progression of IgA nephropathies.

Coppo R, D'Amico G. Coppo R, et al. J Nephrol. 2005 Sep-Oct;18(5):503-12. J Nephrol. 2005. PMID: 16299675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year